Year: 2024
Type: article
Study design: Case Report
Abstract: Adalimumab may be an effective treatment for resistant annular atrophic lichen planus, especially in patients with prior treatment failures and contraindications to other systemic therapies. This case underscores the need for exploring systemic options in challenging cases of this rare lichen planus variant.
Source: Clinical Case Reports
DOI: 10.1002/ccr3.70036
Authors: Joe Khodeir, Paul Ohanian, Marielena Ohanian
Institution: University of Balamand
Language: English
Subfield: Periodontics
Field: Dentistry
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,730
OpenAlex ID: W4405921614
